Medical Journals

Subdepressor Dose of Benidipine Ameliorates Diabetic Cardiac Remodeling Accompanied by Normalization of Upregulated Endothelin System in Rats.

Authors:
  • Jesmin Subrina
  • Hattori Yuichi
  • Maeda Seiji
  • Zaedi Sohel
  • Sakuma Ichiro
  • Miyauchi Takashi

From: Department of Cardiovascular Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: May 2006
  • ISSN: 0363-6135
  • Volume: 290
  • Issue: 5
  • Pages: H2146-54
  • Medium: Print
  • Language: English
  • Citation (JAMA): Jesmin Subrina, Hattori Yuichi, Maeda Seiji, et al. Subdepressor Dose of Benidipine Ameliorates Diabetic Cardiac Remodeling Accompanied by Normalization of Upregulated Endothelin System in Rats.. Am. J. Physiol. Heart Circ. Physiol. May 2006;290:H2146-54

Abstract

We investigated whether benidipine, a long-acting calcium channel blocker (CCB), can normalize cardiac expression profiles of the endothelin (ET)-1 system in insulin-resistant diabetes. Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of human Type 2 diabetes, were treated for 12 wk with vehicle or benidipine (3 mg.kg(-1).day(-1)). OLETF rats exhibited a significant increase in ET-1 in plasma and left ventricular (LV) tissues compared with nondiabetic controls. Expression of prepro-ET-1, ET-converting enzyme, and ET(A) and ET(B) receptors in LV tissues was also significantly higher in OLETF rats. The two MAPKs, JNK and p38MAPK, both of which are activated by ET-1, were more abundantly expressed in OLETF rat LV tissues. All these alterations were reversed to nondiabetic levels when OLETF rats were treated with the subdepressor dose of benidipine. Furthermore, benidipine therapy resulted in hindering cardiomyocyte hypertrophy and cardiac perivascular fibrosis in OLETF rats. The beneficial actions of benidipine at the subdepressor dose on cardiac remodeling in insulin-resistant diabetes may involve normalization of the upregulated ET-1 system.

Mesh Headings (Keywords): Animals, Calcium Channel Blockers, Diabetes Mellitus, Type 2, Dihydropyridines, Dose-Response Relationship, Drug, Endothelin-1, Male, Rats, Up-Regulation, Ventricular Dysfunction, Left, Ventricular Remodeling


Check for Full Text / PubMed Unique Identifier (PMID): 16387788


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.